|
|
Date | Document Type |
Title
|
Issuer/Entity
|
|
13 May 2020
|
Sector In-Depth
|
Not-for-profit and public healthcare - US: Financial effect of coronavirus will hinge on restart of elective services and federal aid
|
|
|
|
03 Sep 2019
|
Median Reports
|
Not-for-profit and public healthcare - US: Medians - Revenues outpace expenses across all regions, yielding financial stability
|
|
|
|
16 Jul 2019
|
LGD Assessment
|
La Financiere ATALIAN S.A.S.
|
La Financiere ATALIAN S.A.S.
|
|
|
03 Apr 2019
|
Sector Comment
|
Health Insurance - Oman: Oman's mandatory health cover plan will spur premium growth
|
|
|
|
26 Jul 2018
|
Sector In-Depth
|
Cross-Sector - Europe: Beyond demographics, cutting costs will be key to affordability of healthcare
|
|
|
|
26 Jul 2018
|
Sector In-Depth
|
Pharmaceuticals - Global: European Investor Roundtables - Q&A Highlights
|
|
|
|
11 Jul 2018
|
Sector In-Depth
|
Pharmaceuticals - Europe: Strong pipelines suggest acceleration of earnings growth into 2019
|
|
|
|
15 May 2018
|
Sector Comment
|
Pharmaceuticals - Global: Proposals to lower US drug prices would be credit negative, if adopted
|
|
|
|
03 May 2018
|
Market Outlook
|
Cross-Sector: Market Data Highlights
|
|
|
|
26 Apr 2018
|
Market Outlook
|
Cross-Sector: Market Data Highlights
|
|
|
|
20 Apr 2018
|
Sector In-Depth
|
Global Pharmaceuticals Snapshot: Pipelines still good while patent expirations will remain modest over next three years
|
|
|
|
19 Apr 2018
|
Outlook
|
Pharmaceuticals - Global: Stable outlook reflects modest earnings growth, but M&A event risk is rising
|
|
|
|
19 Apr 2018
|
Market Outlook
|
Cross-Sector: Market Data Highlights
|
|
|
|
12 Apr 2018
|
Market Outlook
|
Cross-Sector: Market Data Highlights
|
|
|
|
29 Mar 2018
|
Market Outlook
|
Cross-Sector: Market Data Highlights
|
|
|
|
29 Mar 2018
|
Sector Comment
|
Pharmaceuticals - Europe: Divestment of non-core assets will be a source of liquidity in 2018
|
|
|
|
28 Feb 2018
|
Sector Comment
|
Private hospitals - France: France's tariff cut will add to pressure on profitability in 2018, a credit negative
|
|
|
|
08 Dec 2016
|
Outlook
|
Healthcare- Global: 2017 Outlook- Cost Pressures Offset Rising Demand (Presentation)
|
|
|
|
15 Apr 2016
|
Sector In-Depth
|
Pharmaceuticals - Europe: Improvements in Drug Pipelines Bode Well for Medium-term Earnings Growth
|
|
|
|
12 Apr 2016
|
Issuer Comment
|
Grifols S.A.: Acquisition of a 49% Stake in Interstate Blood Bank, Inc. is Credit Positive
|
Grifols S.A.
|
|
|
11 Mar 2016
|
Sector Comment
|
Global Pharmaceuticals: Medicare Drug Pricing Proposal Will be Credit Negative for Branded Pharma Companies if Adopted
|
|
|
|
11 Mar 2016
|
Sector Comment
|
Private Hospitals - France: Tariff Cuts Leave French Private Hospitals Facing Another Year of Lacklustre Growth
|
|
|
|
10 Mar 2016
|
Issuer Comment
|
Grifols S.A.: New Industrial Investments Plan is Credit Positive
|
Grifols S.A.
|
|
|
10 Mar 2016
|
Sector In-Depth
|
Market Liquidity – Advanced Economies: Liquidity Events Are More Likely To Be Fleeting Than Sustained
|
|
|
|
03 Mar 2016
|
Outlook
|
Outlook Update: Global Pharmaceuticals: Change to Stable from Positive on Lower Pricing Flexibility and Stronger Dollar
|
|
|
|
10 Feb 2016
|
Sector Comment
|
Pharmaceuticals - Europe: 2015 Earnings Are In Line with Expectations, but 2016 Outlook Is Less Rosy
|
|
|
|
10 Dec 2015
|
Outlook
|
Healthcare - Global: 2016 Outlook - Demand Will Continue to Rise, Along With Budgetary Pressure (Presentation)
|
|
|
|
15 Jun 2015
|
Special Comment
|
Global Pharmaceuticals: Merck, Roche and Others Challenge Bristol's Lead in Immuno-Oncology
|
|
|
|
11 Jun 2015
|
Sector Comment
|
Global Pharmaceuticals: Sanofi and Amgen Cholesterol Drugs Closer to Market, But Outcomes Data Will be Key
|
|
|
|
28 May 2015
|
Special Comment
|
Global Pharmaceuticals: High Hurdles and High Prices Make Orphan Drugs Appealing M&A Targets
|
|
